Search

VINCRISTINE COOPER 1 MG / 1 ML, Solution Injectable IV (Retiré du marché)

Details

--- Description
Pack Boîte de 1 Flacon de 1 ml
Strength (Dosage)
Laboratory COOPER PHARMA
Ingredients Vincristine
Therapeutic class Cytostatique, alcaloïde de la pervenche
ATC code L01CA02
PPH $4.06
PPV $6.50
Refundable Yes
Refund base $6.50
Refund rate $0.00
Table A
Marketing status Commercialized
Type Medication
Uses La vincristine est généralement utilisée en polychimiothérapie dans les indications suivantes:

- induction et consolidation de la rémission de la leucémie aiguë lymphoblastique ;
- maladie de Hodgkin ;
- lymphomes non hodgkiniens ;
- cancer du sein métastatique (traitement palliatif des cas résistants aux traitements usuels) ;
- cancer bronchique à petites cellules ;
- sarcomes (sarcome ostéogénique, sarcome d’Ewing, rhabdomyosarcome);
- tumeur de Wilms ;
- neuroblastome.

Monothérapie :
- purpura thrombopénique idiopathique résistant aux traitements usuels (maladie de Werlhof).
Warnings
Dosage
Avoid
Side effects
Interactions

Medications with one or more of the ingredients above


Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.